We have developed an automated enzymatic assay for quantitation of inulin in plasma and urine that can be performed on the Cobas FARA II. In the assay, inulinase hydrolyzes inulin to fructose, and sorbitol dehydrogenase converts fructose to sorbitol with consumption of NADH, which is detected by spectrophotometry.
The most important measurement in assessing renal function is glomerular filtration rate (GFR) (1). Serum creatunine measurement is the most common method for estimating GFR because creatinine is endogenously produced, is fast and simple to measure, and provides a reasonable assessment of renal function in most medical situations. However, serum creatinine concentrations are relatively insensitive to GFR changes, because serum concentrations may not be abnormally increased until there is >50% loss of normal renal function (2,3). Significant amounts of creatinine may be secreted by the renal tubule, and secretion increases with increasing renal failure, blunting the expected increase in serum creatinine concentrations and resulting in overestimation of GFR (4) . Creatinine clearance improves estimation of the GFR over serum creatinine measurement alone, but requires timed urine collection, which adds additional sources of error (5). Although estimations of GFR and analytical imprecision become much more significant (6) .
A classic alternative method of measuring GFR is inulin clearance (for review, see 7). Inulin is a polysaccharide composed largely of fructose, with small amounts of glucose. From a metabolic standpoint, it is ideal for measuring GFR because it is freely filtered by the glomeruli and is not reabsorbed, secreted, or metabolically altered by the renal tubule. The principal disadvantage of this method is that inulin is not endogenously produced and thus requires intravenous adininistration with a long infusion time. Accurate determination of GFR requires several timed plasma and urine measurements.
The most widely accepted laboratory method for quantitating inulin in plasma and urine is the anthrone reaction (8), which is based on the hydroiysis of inulin in hot concentrated sulfuric acid and condensation with anthrone to yield a green product that is read spectrophotometrically at 620 nm. The anthrone method is labor-and time-intensive, and other sugars such as glucose may interfere with the assay (8).
We have modified an enzymatic method, first proposed by Day and Workman (9), utilizing inuliriase and sorbitol dehydrogenase to measure inulin. Our method is automated, fast, avoids the use of toxic reagents, and minimi7es interference by glucose.
Materials and Methods

Specimens
Specimens for inulin analysis were obtained from pediatric patients at St. Louis Children's Hospital for routine physician-ordered renal assessment and in accordance with the requirements set for the study by the institutional review board. Briefly, a bolus loading dose of inulin was given via the antecubital vein and a continuous infusion (21 mJ.dh) was begun. The inulin concentration given to each patient was determined 20 L of an infusate diluted 50-to 1000-fold with 40 g/L BSA Properly diluted urine and infusate specimens could be analyzed in the same run as undiluted placmn Specimens could be stored at 4#{176}C 1 week before analysis. The specimen was mixed on the analyzer with 100 pL of inuli- Because fructose concentrations generated during the assay were well below the Km, a high concentration of sorbitol dehydrogenase (6.4 U added) was needed to catalyze the reaction in a timely manner.
We compared the recovery of a known amount of fructose and inulin added to plasma when the calibrator was made in water with recovery calculated by means of we used a calibrator prepared in 40 g/L BSA, which effectively compensated for the matrix effect. The assay was linear for inulin concentrations up to 300 mg/L of inulin ( Figure  1) , with an apparent recovery of 99% (y = 0.99x + 5). Because hydrolysis of 1 mg of inulin yields 1.11 mg of hexose, due to the addition of a water molecule to each sugar monomer, recovery could exceed 100%; however, glucose is not measured by the assay (see below), and recovery of fructose from inulin hydrolysis will be reduced with increasing glucose content of the inulin. Patients' specimens were analyzed by both the anthrone and the enzymatic assay. Values obtained from the anthrone assay (x) on plasma samples averaged slightly higher by a constant 3.5 mg/L than those from the enzymatic assay (y) (y = 1.OOx -3.5; S = 5.5; Figure 2, left) . The small constant bias between assays was not clinically significant.
The correlation of urine and infusate analyses was excellent (y = 1.OOx -138; S = 714; Figure 2 , right). Because urine/infusate values are typically >3000 mglL, the apparent constant bias of -138 mgfL was proportionally minor.
Interference by endogenous fructose and glucose was evaluated. Specimens from routine clinical inulin infusions (47 plasma and 21 urine, from fasting patients) were analyzed with the enzymatic method, omitting inulinase, to determine whether background fructose concentrations were significant. Background fructose concentrations in patients' plasma specimens ranged from 15 to 50 mgIL, but urine specimens contained negligible amounts. In another experiment, plasma specimens were collected from an individual just before and 1 h after ingestion of a soft drink containing fructosebased sweetener, and analyzed for apparent inulin (no inulin was infused). The anthrone analysis of the 1-h postingestion specimen yielded a value of 117 mg/L; subtraction of the zero-hour blank (15 mgfL) left an inulin content for the specimen of 102 mgfL. Enzymatic analysis of the 1-h postingestion specimen yielded 143 mgfL, but the inactivated inulinase value on the same specimen was also 143 mgfL; the net inulin was zero. Because these concentrations were significant in relation to the fructose generated by inulin hydrolysis, a blank determination (heat-inactivated inulinase) was incorporated into the standard procedure. All the results presented here incorporated blank determinations. Glucose is a known interfering substance in the anthrone assay (14) . When 300 mgfL glucose was added to plasma and the anthrone assay was used, the equivalent of 33 mgIL inulin was detected. When the same solution was analyzed by the enzymatic method, the inulin detected was only 1.3 mgIL. Interference studies performed with sorbitol, mannitol, and xylitol showed that none of these substances was detected as inulin by either method over a range of 0-300 mg/L.
The precision of the assay was assessed by running daily quality-control plasma and urine samples for several weeks. The CV for plasma was 1.4% ( = 160 mg'L, SD = 2.3 mg'L; n = 20) and for urine, 4.0% ( 2390 mg/L, SD = 96 mgfL; n = 25). The anthrone assay had a CV of 2.8% ( = 645 mgIL, SD = 18 mgfL) for repeated analysis of a serum control.
DiscussIon
The anthrone method is currently the laboratory method most often used for quantifying inulin concentrations in serum and urine despite its inherent technical difficulty, labor intensiveness, and sensitivity to interfering substances (8, 14, 15 ). The enzymatic method described here improves the laboratory determination of inulin concentrations by eliminating the use of caustic reagents and by automating the method, which significantly reduces technical and labor constraints. The first enzyme in this assay hydrolyzes inulin into its individual fructose units (10, 11) . Enzymatic hydrolysis avoids the hot acid hydrolysis used in the anthrone reaction. Sorbitol dehydrogenase, catalyzing the second reaction, specifically converts fructose to sorbitol, eliminating nonspecific reactions with other sugars, which may occur in the anthrone assay (12, 13, 16 ). The consumption of stoichiometric amounts of NADH by sorbitol dehydrogenase allows analysis of the reaction by conventional spectrophotometry in centrifugal and other standard clinical analyzers. Because aldose sugars such as glucose are not substrates for this enzyme (12), interference studies performed with glucose in this assay system show <1% reactivity.
Glucose interference in the anthrone method has limited the applicability of inulin clearance studies in diabetics, in whom plasma glucose concentrations may vary considerably during the several-hour infusion period. The present method, by nearly eliminating glucose interference, makes inulin clearance testing in diabetics more accurate. Recovery studies performed with known amounts of fructose and inulin showed that the enzymatic assay had excellent recovery and was linear up to a concentration of 300 mgfL, which covers the range of concentrations of inulin achieved in plasma during standard infusions. When patients' specimens were analyzed by both methods, we found good correlations between the enzymatic and anthrone methods for both plasma and urine. The precision of the enzymatic method was comparable with that of the anthrone method, with both assays yielding CVs of 1-4% in daily analysis of quality-control plasma and urine specimens. Several recent publications have offered methods for inulin measurement designed to decrease interference by glucose and to speed analysis (17-19), but none is fully automated and all require more time to perform than the method described here. An HPLC method (17) has been developed that eliminates the potential interference of glucose and other noninulin chromophores in the anthrone method, but specimens must be analyzed singly on dedicated equipment. Enzymatic methods have been described that utilize inulinase for hydrolysis of inulin and convert the liberated fructose to glucose 6-phosphate for oxidation to gluconate 6-phosphate (18) (19) (20) ; these manual methods involve a cascade of several enzymes and are not easily automated. Glucose oxidase may be added before the hydrolysis step to oxidize endogenous glucose and eliminate glucose interference in subsequent enzymatic steps (18, 20) . The overall time required for these two-step analyses exceeds 2 h. The method presented here was first proposed by Day and Workman (9) as a manual procedure, but was not evaluated for clinical use.
The physiological presence of fructose in plasma creates background interference for both the enzymatic and anthrone methods. The anthrone method requires a plasma specimen collected just before inulin infusion begins; the value of this specimen is subtracted as a blank from the values obtained for plasma specimens collected during infusion. This blanking mechanism assumes that the background presence of noninulin chromophores stays constant during the 3-4-h infusion, which may not be true for patients such as diabetics. Preinfusion ingestion of fructose-or sucrose-containing foods could also affect the blank value used in the anthrone method-based calculations; subsequent metabolism of the fructose over the subsequent several-hourslong infusion would decrease the background color development for subsequently drawn plasma specimens, and thereby underestimate the actual inulin concentration and artifactually increase the calculated GFR. The enzymatic method, incorporating a true blank for each specimen, eliminates the potential for both overestimation and underestimation of inulin clearance in patients who are not fasting, which is an advantage for measurements in children and noncompliant patients.
